의료 권고사항

Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age [2022-10-21]

National Advisory Committee on Immunization예방접종2022보관된 문서

ASEM 문헌 요약

Official National Advisory Committee on Immunization document (2022) on “Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age [2022-10-21]”. NACI recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years, including summary of evidence, clinical trial and safety data, authorized preparations and schedule.

이 요약은 문서를 식별하는 데 도움이 됩니다. 임상 권고사항은 항상 공식 버전과 업데이트 날짜를 확인하십시오.

공식 문서